Security key
03969T109
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
CUSIP: 03969T109
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 28,423,877
- Total 13F shares
- 4,612,453
- Share change
- +2,719,990
- Total reported value
- $47,342,000
- Put/Call ratio
- 106%
- Price per share
- $10.27
- Number of holders
- 39
- Value change
- +$27,908,866
- Number of buys
- 31
- Number of sells
- 3
Report period
Q3 2019
Institutions
39
Top holders
10
ARCT full security history
Newer quarter: Q4 2019
Previous quarter: Q2 2019
Arcturus Therapeutics Holdings Inc. SEC filings
Arcturus Therapeutics Holdings Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969T109
Recent filing periods:
Top shareholders of ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
|
Company |
3.5%
|
1,004,368
|
$9,481,000 | — | 30 Jun 2019 | |
| HIGHLINE CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.77%
|
217,866
|
$2,057,000 | — | 30 Jun 2019 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
0.46%
|
129,974
|
$1,227,000 | — | 30 Jun 2019 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.46%
|
129,974
|
$1,227,000 | — | 30 Jun 2019 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.37%
|
106,436
|
$1,005,000 | — | 30 Jun 2019 | |
| Creative Planning |
13F
|
Company |
0.21%
|
60,971
|
$576,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
43,190
|
$408,000 | — | 30 Jun 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
41,153
|
$388,000 | — | 30 Jun 2019 | |
| Diametric Capital, LP |
13F
|
Company |
0.13%
|
38,207
|
$361,000 | — | 30 Jun 2019 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.1%
|
27,300
|
$258,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.08%
|
23,548
|
$222,000 | — | 30 Jun 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
17,517
|
$165,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
13,473
|
$127,000 | — | 30 Jun 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.05%
|
13,245
|
$128,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,919
|
$28,000 | — | 30 Jun 2019 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
2,421
|
$22,000 | — | 30 Jun 2019 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.01%
|
2,400
|
$23,000 | — | 30 Jun 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,165
|
$11,000 | — | 30 Jun 2019 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
900
|
$8,000 | — | 30 Jun 2019 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
625
|
$6,000 | — | 30 Jun 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
171
|
$2,000 | — | 30 Jun 2019 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
144
|
$1,000 | — | 30 Jun 2019 |
Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q3 2019
As of 30 Sep 2019,
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,612,453 shares.
The largest 10 holders included
ARK Investment Management LLC, DFPG INVESTMENTS, INC., TOWNSQUARE CAPITAL LLC, FMR LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., DAFNA Capital Management LLC, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, and ROYCE & ASSOCIATES LP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
20
Q3 2019 holders
39
Holder diff
19
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.